Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006–January 2008
- 2 December 2008
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 26 (51), 6529-6541
- https://doi.org/10.1016/j.vaccine.2008.08.067
Abstract
We analysed country recommendations and funding plans finalized through January 2008 for the inclusion of quadrivalent and bivalent human papillomavirus (HPV) vaccines in national immunization programmes. Fifteen industrialized countries have recommended HPV vaccine use based on careful review of scientific evidence and cost-effectiveness. There was a strong consensus among the guidelines regarding assessment of vaccine safety and efficacy, selection of primary target populations for vaccination, vaccine delivery strategies, and the need for vaccinated females to seek cervical cancer screening. The analysis informs ongoing discussions in several countries considering HPV vaccines for national immunization programmes and discussions at the World Health Organization about global recommendations for HPV vaccine use for national immunization programmes.Keywords
This publication has 20 references indexed in Scilit:
- HPV and cervical cancer: screening or vaccination?British Journal of Cancer, 2008
- Prevention and control of viral hepatitis through adolescent health programmes in EuropeVaccine, 2007
- The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource settingBritish Journal of Cancer, 2007
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult WomenPublished by American Academy of Pediatrics (AAP) ,2006
- Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccinesVaccine, 2006
- Chapter 15: HPV vaccine use in the developing worldVaccine, 2006
- Chapter 14: HPV vaccine introduction in industrialized countriesVaccine, 2006
- Exploring the Knowledge, Attitudes, Beliefs, and Communication Preferences of the General Public Regarding HPVHealth Education & Behavior, 2006
- Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccinationVaccine, 2006